Quality by design optimization of microemulsions for topical delivery of Passiflora setacea seed oil

• Daniel T. Pereira,
• Douglas Dourado,
• Danielle T. Freire,
• Dayanne L. Porto,
• Cícero F. S. Aragão,
• Myla L. de Souza,
• Guilherme R. S. de Araujo,
• Ana Maria Costa,
• Wógenes N. Oliveira,
• Anne Sapin-Minet,
• Éverton N. Alencar and
• Eryvaldo Sócrates T. Egito

Beilstein J. Nanotechnol. 2025, 16, 2116–2131, doi:10.3762/bjnano.16.146

• poor physicochemical and organoleptic properties. This study aimed to develop and optimize a topical microemulsion (ME) system incorporating P. setacea seed oil using quality by design principles to address formulation challenges. The oil was extracted via Soxhlet and characterized by gas

• assays demonstrated high cell viability for ME at concentrations below 2 mg/mL in RAW 264.7 macrophages and 0.5 mg/mL in human umbilical vein endothelial cells. Overall, this work presents a promising nanotechnology-based topical delivery platform for P. setacea seed oil, employing quality by design

• principles to ensure formulation performance, stability, and skin cell compatibility. Keywords: design of experiments (DoE); microemulsions; nanotechnology; natural products; passion fruit; quality by design; skin delivery; Introduction Species of the Passiflora genus are known for their rich composition

Polymer lipid hybrid nanoparticles for phytochemical delivery: challenges, progress, and future prospects

• Iqra Rahat,
• Pooja Yadav,
• Aditi Singhal,
• Mohammad Fareed,
• Jaganathan Raja Purushothaman,
• Mohammed Aslam,
• Raju Balaji,
• Sonali Patil-Shinde and
• Md. Rizwanullah

Beilstein J. Nanotechnol. 2024, 15, 1473–1497, doi:10.3762/bjnano.15.118

• against MDA-MB-435s cells. Further, the targeted PLHNPs also showed better cytotoxic effects against MCF-7 cells. In another study, Ma et al. fabricated HCT-loaded PEGylated PLHNPs and optimized them by the “Quality by Design” approaches such as Plackett–Burman and Box–Behnken designs [127]. The developed

• CHS-based mucoadhesive PLHNPs in improving PRN’s intestinal permeation, oral bioavailability, and anti-BC activity [154]. The developed PLHNPs were optimized by the “Quality by Design” approach. The optimized PRN-PLHNPs were stable in the GI milieu and showed excellent mucoadhesive strength and

Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent

• Horacio Emanuel Jerez,
• Yamila Roxana Simioni,
• Kajal Ghosal,
• Maria Jose Morilla and
• Eder Lilia Romero

Beilstein J. Nanotechnol. 2024, 15, 517–534, doi:10.3762/bjnano.15.46

• increasingly pursued “quality by design” criteria [24]. The development of structurally simple formulations that facilitate their scaling and further characterization is, therefore, a critical task [25]. Also, targeting nanomedicines to circulating cells and vascular walls is difficult since it should occur

Fabrication of nanocrystal forms of ᴅ-cycloserine and their application for transdermal and enteric drug delivery systems

• Hsuan-Ang Tsai,
• Tsai-Miao Shih,
• Theodore Tsai,
• Jhe-Wei Hu,
• Yi-An Lai,
• Jui-Fu Hsiao and
• Guochuan Emil Tsai

Beilstein J. Nanotechnol. 2024, 15, 465–474, doi:10.3762/bjnano.15.42

• smaller particle size. In addition, we used Quality by design (QbD) to generate parameters that can be applied to commercial products in the future. The QbD is a systematic approach to drug development that ensures that a product is of high quality and consistently meets the desired characteristics